News
Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of ...
The Canadian Press on MSN16h
Health Canada approves Ozempic for kidney protection in Type 2 diabetics
Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes. Between ...
TORONTO - Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes ...
Pfizer said Health Canada has approved its latest COVID-19 vaccine that targets a new Omicron variant. It will be made available in the fall.
The law gives Quebec's labour minister the power to end a labour dispute by imposing arbitration when the strike or lockout is deemed likely to cause serious harm to the public.
8h
TipRanks on MSNIovance Biotherapeutics Gains Health Canada Approval
Iovance Biotherapeutics ( ($IOVA) ) has shared an update. On August 18, 2025, Iovance Biotherapeutics announced that its product Amtagvi® ...
The joint recall includes Health Canada, the United States Consumer Product Safety Commission and i-Drink Products Inc.
12h
Stocktwits on MSNHealth Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline, Cardiovascular Death
Danish drugmaker Novo Nordisk (NVO) on Tuesday said that its blockbuster drug Ozempic is now approved in Canada to reduce the ...
5don MSN
As Canada wildfires choke US with smoke, Republicans demand action. But not on climate change
Republican lawmakers are blaming Canada for not preventing and containing wildfires, whose smoke has fouled the air in ...
Canada has approved a first-of-its-kind drug for multiple myeloma, a significant advancement in the treatment of a cancer that has no cure.
First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD-1 and targeted therapy SAN CARLOS, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results